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Primate lentiviruses are composed of several distinct lineages, including human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian
immunodeficiency virus SIVagm. HIV-1 and HIV-2 have significant differences in the mechanisms of viral RNA encapsidation. Therefore, the
RNA packaging mechanisms of SIVagm cannot be predicted from the studies of HIV-1 and HIV-2. We examined the roles of the nucleocapsid
(NC) zinc finger motifs on RNA packaging by mutating the conserved zinc finger (CCHC) motifs, and whether SIVagm has a preference to
package RNA in cis by comparing the RNA packaging efficiencies of gag mutants in the presence of a wild-type vector. Our results indicate that
the SIVagm NC domain plays an important role in Gag–RNA recognition; furthermore SIVagm is distinct from the other currently known primate
lentiviruses as destroying either zinc finger motif in the NC causes very drastic RNA packaging defects. Additionally, trans-packaging is a major
mechanism for SIVagm RNA encapsidation.
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In all known retroviruses, full-length viral RNAs are
specifically encapsidated into the virions (Vogt, 1997). This
specific encapsidation of the viral genomic RNA is based on
interactions between the viral protein Gag and the packaging
signal in the viral RNA (Berkowitz et al., 1996; Lever, 2000;
Luban and Goff, 1991). The major packaging signals have been
identified in many retroviruses; in most cases, the sequences are
located at the 5′ untranslated region of the viral genome and
often extend into the gag gene sequences (Adam and Miller,
1988; Aldovini and Young, 1990; Bender et al., 1987;
Berkowitz et al., 1995a; Embretson and Temin, 1987; Kaye et
al., 1995; Lever et al., 1989; McBride and Panganiban, 1996;
Mougel and Barklis, 1997). Gag has at least three domains:
matrix (MA), capsid (CA), and nucleocapsid (NC) (Leis et al.,⁎ Corresponding author. Fax: +1 301 846 6013.
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doi:10.1016/j.virol.2007.01.0301988; Vogt, 1997). Additionally, most viruses have other
domains that are varied in size and location. For example,
human immunodeficiency virus type 1 (HIV-1) has spacer
peptide 1 (SP1, also known as p2) located between CA and NC
domains, and SP2 (also known as p1), and p6 that are C-
terminal to the NC domain. Of the Gag domains, NC is known
to play an important role in RNA recognition (Berkowitz et al.,
1995b; Certo et al., 1999; Kaye and Lever, 1998; Rein et al.,
1994; Zhang and Barklis, 1995); the MA domains of some
viruses are thought to also interact with nucleic acid (Katoh et
al., 1991; Ott et al., 2005; Poon et al., 1998).
With the exception of spumaviruses, retroviral NC domains
contain one or two conserved motifs with the C–X2–C–X4–H–
X2–C (CCHC) sequence, which have similarity to some known
cellular zinc finger motifs that bind zinc. The CCHC motif has
been shown to bind zinc in a number of viruses (Bess et al.,
1992; Green and Berg, 1989; Summers et al., 1992);
furthermore, zinc binding is essential for the function of the
motif as a zinc-ejecting agent causes the loss of viral infectivity
in HIV-1 (Rossio et al., 1998). The CCHCmotif is critical to NC
function; mutations that destroy the zinc-binding ability of the
CCHCmotif often lead to loss of viral infectivity and significant
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1990; Gorelick et al., 1988, 1990; Kaye and Lever, 1999).
Interestingly, varied effects have been observed when replacing
the CCHC motif with other zinc finger motifs such as CCCC or
CCHH. In murine leukemia virus (MLV), substituting CCHC
with CCCC or CCHH did not affect viral RNA encapsidation,
but these mutant viruses had other defects and were
noninfectious (Gorelick et al., 1996). In HIV-1, substituting
the CCHC/CCHC motifs with CCCC/CCHC, CCHC/CCCC, or
CCCC/CCHH generated viruses that efficiently package viral
RNAs. However, replacing the motifs with CCCC/CCCC or
CCHH/CCCC resulted in viruses that did not efficiently
package viral RNA (Gorelick et al., 1999b). Therefore, there
are far more subtle features in the conserved CCHC sequences
than the simple ability to bind zinc, and other zinc finger motifs
may not be able to replace the authentic sequences. Addition-
ally, for those viruses with two CCHC motifs, the individual
motifs may have different contributions to various NC functions
and they cannot replace each other's function (Gorelick et al.,
1993). This effect is illustrated in the analyses of the two CCHC
motifs in HIV-1. Disruption of the N-terminal zinc finger motif
had a more drastic effect in the loss of viral RNA encapsidation
(Gorelick et al., 1990). Replacing the N-terminal CCHC motif
with the C-terminal CCHC motif, thereby generating a virus
with two C-terminal motifs, resulted in a significant decrease of
viral RNA encapsidation and loss of viral infectivity. Replacing
the C-terminal CCHC motif with that of the N-terminal motif
resulted in a virus that packaged viral RNA but also had
decreased infectivity (Gorelick et al., 1993). These studies
indicated that the two CCHC motifs contribute distinctive
functions to NC; the N-terminal zinc finger contributes more to
RNA packaging. Interestingly, although preserving the CCHC
motif(s) is critical for RNA packaging in most viruses, there are
exceptions. For example, simian immunodeficiency virus strain
mne (SIVmne), a different primate lentivirus, has two CCHC
motifs in the NC domain. SIVmne does not require both NC
zinc finger motifs for RNA packaging—destroying either motif
does not significantly affect RNA packaging (Gorelick et al.,
1999a). Therefore, different viruses may have varied require-
ments for the CCHC motifs in RNA packaging.
Full-length genomic RNA is both the genetic material
packaged into virions and the template for the translation of
Gag/Gag–Pol (Butsch and Boris-Lawrie, 2002). There are two
contrasting mechanisms proposed for Gag–RNA interaction:
the cis- and trans-packaging mechanisms. The cis-packaging
mechanism proposes that Gag encapsidates the RNA from
which it was translated, whereas the trans-packaging mechan-
ism suggests that Gag does not have a strong preference to
package the RNA from which it was translated. It has been
shown that two separate pools of RNAs exist during the
replication of some viruses, such as MLV (Levin et al., 1974;
Levin and Rosenak, 1976). One pool of RNA serves as the
template for Gag/Gag–Pol translation and the other pool of
RNA serves as the substrate for packaging into newly produced
virions (Levin and Rosenak, 1976). When two separate pools of
RNA exist for translation and encapsidation, RNA packaging
mechanisms must occur predominantly in trans. In otherviruses, such as HIV-1 and HIV-2, there is no evidence
currently supporting the presence of two separate pools of RNA
for translation and encapsidation (Butsch and Boris-Lawrie,
2000; Dorman and Lever, 2000). Therefore, in these viruses,
RNA encapsidation could occur via either the cis- or trans-
packaging mechanism. Interestingly, viruses from the same
genus may not use the same mechanism for RNA packaging.
For example, HIV-1 Gag efficiently packages RNA in trans
(Butsch and Boris-Lawrie, 2000; Kaye and Lever, 1999;
Nikolaitchik et al., 2006); in contrast, HIV-2 Gag preferentially
packages RNA in cis (Kaye and Lever, 1999).
Primate lentiviruses consist of two human pathogens, HIV-1
and HIV-2, and SIVs that infect many species of nonhuman
primates in Africa. Most of the primate lentiviruses can be
assigned to six phylogenetic lineages (Hahn et al., 2000; Salemi et
al., 2003). Among them, three major lineages include (1) SIVcpz,
and its zoonotic derivative, HIV-1 (Gao et al., 1999; Huet et al.,
1990); (2) SIVsm, its zoonotic derivative, HIV-2, and other SIVs
that infect macaques (Chen et al., 1996; Hirsch et al., 1989;
Novembre et al., 1992); and (3) SIVagm (Muller, 2003; Soares et
al., 1997). In addition to the important human pathogens, HIV-1
and HIV-2, much research interest has been focused on SIVagm
because the virus–host interactions revealed interesting features of
SIVagm infection. Much like HIV-1, SIVagm generates high viral
loads in the infected host (African green monkey); however, in
sharp contrast to HIV-1, SIVagm does not cause immunodefi-
ciency in the infected animal (Broussard et al., 2001; Hirsch,
2004). Despite interest in the pathogenesis of the virus, very little is
known about the replicationmechanisms of SIVagm. In this report,
we examined the molecular mechanisms of SIVagm RNA
packaging. Most of the studies on mechanisms of RNA packaging
in primate lentiviruses have been performed using HIV-1 or HIV-2
or viruses closely related to HIV-2. These studies revealed that
there are significant differences between HIV-1 and HIV-2 RNA
packaging mechanisms such as the aforementioned cis- and trans-
packaging. Therefore, the mechanisms of SIVagm RNA packa-
ging cannot be predicted from the HIV-1 and HIV-2 studies. In this
report, we found that both zinc finger motifs of the NC domain are
important in SIVagm RNA encapsidation, because destroying
either motif caused a drastic decrease in RNA packaging. We also
found that SIVagm Gag can efficiently package the viral genome
in trans. We conclude that trans-packaging is the predominant
mechanism for SIVagm Gag–RNA interaction.
Results
Modified SIVagm used to study the effects of NC mutation on
viral replication
To study the trans-acting elements important for SIVagm
viral RNA packaging, we examined the roles of the CCHC zinc
finger motifs in the NC domain of Gag. We generated SIVagm-
based vectors derived from pTan, which contained the full-
length viral genomes. Two modifications were made to generate
pTan-IHSA: a frameshift mutation was introduced into env and
a DNA fragment containing IRES-hsa was inserted into nef.
The general structure of pTan-IHSA is shown in Fig. 1A. The
Fig. 1. Wild-type and NC mutants used to study the role of NC in SIVagm RNA
encapsidation. (A) General structure of the SIVagm-based vector. Asterisks
indicate inactivating mutations. I, IRES. (B) NC mutants examined in this study.
The two CCHC motifs and modifications are indicated.
Fig. 2. The effects of NC mutations on viral infectivity and RNA packaging. (A)
Viral infectivity generated by vectors with wild-type or mutant NC domains and
measured in one round of virus replication. Infectivity of the wild-type virus is
set as 100%. (B) Efficiency of SIVagm viral RNA encapsidation by viruses
generated by vectors with wild-type or mutant NC domains. The wild-type virus
RNA packaging is set as 100%. The results from at least three sets of
independent experiments are summarized; error bars, standard deviations.
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of mutations were introduced into the NC zinc finger motifs by
site-directed mutagenesis; these mutations are shown in Fig. 1B.
The conserved zinc finger motifs were either destroyed by
changing the CCHC motif with SSHS or replaced with a
different zinc finger motif such as CCCC or CCHH.
The effects of NC mutations on viral replication
To examine the effects of NC mutations on viral replication,
we cotransfected each vector with an HIV-1 Env-expressing
plasmid, pIIINL(AD8)env, into 293T cells. Because 293T cells
do not express CD4 and CCR5, receptor and coreceptor of the
HIV-1 AD8 strain Env, reinfection does not occur in this system.
Virus was harvested from transfected cells, a portion of the virus
was used to infect human T cell line Hut/CCR5, and another
portion was reserved for biochemical analyses. Viral titers
generated by wild-type or NC mutant vectors were measured by
the expression of the HSA marker in the target cells.
We measured particle production from the wild-type and the
various mutants virus using the capsid (p27) capture assay. In
three independent experiments, the p27 values generated from
all of the mutants were generally within twofold of the wild-
type viruses, indicating that none of the mutants had severe
defects in virion production (data not shown). Generally, the
wild-type vectors generated robust viral titers and infected at
least 40% of the cells based on HSA marker expression (HSA+).
To compare the infectivity of the viruses generated by the wild-
type virus and the NC mutants, we measured the number ofHSA+ cells in the infected cells, converted the percentage of
infected cells into MOI, and then normalized the number to p27
amounts. Results summarized from three independent experi-
ments are shown in Fig. 2A, with the wild-type titer defined as
100%. Eliminating either or both of the CCHC zing finger
motifs by changing the sequence to SSHS abolished detectable
viral titers. Similarly, replacing either CCHC motif with CCCC
reduced the viral titers to undetectable levels. However,
replacing the CCHC motifs with CCHH had variable effects.
When the N-terminal CCHC was changed to CCHH (CCHH/
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detectable, amounts of infected cells (∼0.6% of the wild-type
titer). When the C-terminal CCHC was changed to CCHH
(CCHC/CCHH), the resulting viruses had high virus titers; after
normalizing the titers to the virus production (p27 values), we
determined that this mutant generated virions with approxi-
mately 60% of the wild-type virus infectivity (Fig. 2A).
The effects of NC mutations on viral RNA packaging
The amounts of SIVagm RNA packaged by various NC
mutants were determined by quantitative real-time PCR of
viruses produced from cells infected with an SIVagm vector. To
avoid possible contamination of the transfected DNA in the
virion RNA preparation, we generated pools of cells, each
expressing proviruses from one of the NC mutants. The 293T
cells were cotransfected with NC mutants, a helper construct
expressing HIV-1 gag–pol but lack cis-acting elements essential
for viral replication, and a plasmid expressing VSV G. We have
observed that HIV-1 gag–pol can transduce SIVagm genome
(Fu and Hu, unpublished results). The resulting viruses were
harvested and used to infect fresh 293T cells to generate cell
pools containing various NC mutants. Viruses generated from
these cell pools did not have functional Env and could not
reinfect the cells. We then harvested viruses from these cell
pools, measured their virion production by p27 assay, and the
amount of RNA packaged in the virion by real-time quantitative
RT-PCR using primers and probe that annealed to gag of
SIVagm. The amounts of RNA packaged were standardize to the
p27 amounts; because NC mutant vector RNAwas used both as
substrate for viral proteins translation and for encapsidation, this
method measured the efficiencies of RNA packaging by various
NCmutants. Data from four independent sets of experiments are
summarized in Fig. 2B. Abolishing either one of the CCHC
motifs rendered the virus unable to efficiently package viral
RNA. Altering the CCHC sequences to other zinc finger motifs
had variable effects on RNA packaging. When either the N- or
C-terminal CCHC was changed to CCCC, the resulting mutant
proteins did not package viral RNA efficiently. However, all of
the CCHH mutants were able to package some levels of viral
RNA. Compared with the wild-type virus, the CCHH/CCHC
mutant packaged at a fivefold reduced efficiency, whereas the
CCHC/CCHH mutant packaged at levels similar to those of
wild-type viruses.
Taken together, these data indicated that abolishing the zinc
finger motif by replacing CCHC with SSHS, or substituting
either one of the CCHC motifs with CCCC resulted in loss of
viral RNA packaging and viral infectivity. Therefore, both of the
NC zinc finger motifs play important roles in the selection of viral
RNA during the processes of virus assembly and replication.
System used to determine whether SIVagm Gag predominantly
packages viral RNA in cis
To determine the mechanism(s) of SIVagm RNA packaging,
we compared the packaging efficiencies of two coexpressed
SIVagm RNAs, one carrying wild-type gag and the othercarrying a mutant gag, in a competition assay. If Gag proteins
predominantly package the RNA from which they were
translated, then the wild-type Gag proteins will predominantly
package the RNA of the wild-type vector. Because the mutant
Gag proteins cannot efficiently package viral RNA, the mutant
vector RNAwill not be efficiently packaged, thereby creating a
strong bias to package wild-type vector RNA in this system. In
contrast, if SIVagm Gag proteins do not preferentially package
in cis, then the both the wild-type RNA and the RNA containing
mutant gag gene should be packaged efficiently.
We generated vectors that contained wild-type or mutant gag;
the structures of these vectors are shown in Fig. 3A. The general
structures of these vectors are similar to those described in Fig. 1.
However, the vectors used to examine packaging mechanisms
carry either a functional hsa or a functional thy; additionally,
each vector contains an IRES and a mutated gfp. The two vectors
containing wild-type gag genes are pTanH0G and pTanT6G,
which carry an hsa and a thy marker gene, respectively. We also
constructed three vectors containing gag mutations; all of these
mutants carry thy markers (Fig. 3A). Vector pTanT6GS239*
contains a stop codon at codon 239 of Gag, thereby creating a
truncation in the CA domain. Additionally, we generated two
vectors with mutations in the NC zinc finger motifs; each
mutation severely inhibited the packaging of viral RNA into
virions (Fig. 2B). The N-terminal CCHC motif in pTan-
T6G1SSHS was changed to SSHS, and the C-terminal CCHC
motif in pTanT6G2CCCC was changed to CCCC.
In this experimental design, the expression of both wild-type
and mutant vectors is required to generate virions containing the
mutant vector RNA, whereas the expression of the wild-type
vector is sufficient to produce particles encapsidating the wild-
type RNA. Therefore, if the two viruses are not properly
coexpressed in most of the cells, biased results could be
generated. To ensure that most of the virus producer cells express
both vectors, we generated cell lines expressing both proviruses
and examined virions generated from these producer cells. The
experimental protocol is illustrated in Fig. 3B. Producer cell lines
containing a wild-type vector and a mutant vector were generated
by sequentially infecting 293Tcells at lowMOIs, between 0.1 and
0.05. Low MOIs were used to avoid the presence of multiple
proviruses from the same vector in a significant portion of the
cells. Dually infected cells were enriched by sorting until more
than 95% of the cells expressed both HSA and Thy markers. In
general, each producer cell line contains at least 100,000
independent infection events. We then compared the cellular
RNA expression, preference of RNA packaging into the virions,
and viral titers generated by the wild-type and gagmutant vectors.
Comparison of viral titers generated by the wild-type and
mutant vectors
We generated a total of eight cell lines. Two cell lines were
infected with two wild-type vectors, TanH0G and TanT6G. Six
cell lines were infected with a wild-type vector, TanH0G, and a
mutant vector, TanT6GS239*, TanT6G1SSHS, or TanT6-
G2CCCC; two independent cell lines were generated for each
combination of vectors.
Fig. 3. Vectors and experimental protocol used to examine whether SIVagm Gag
packages RNA in cis. (A) General structures of vectors used to study
mechanisms of RNA packaging. Abbreviations are the same as in Fig. 1; gag
mutations are as indicated. (B) Experimental protocol used to establish producer
cell lines coexpressing two vectors and to determine virus titer and RNA content
in cells and virions.
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in env; therefore, virions generated from producer cell lines
cannot reinfect producer cells or infect new target cells. To
compare the titers generated by the wild-type and mutant
vectors, we transfected the producer cells with pIIINL(AD8)env
plasmid, which expresses env of the AD8 strain of HIV-1. The
resulting viruses were used to infect Hut/CCR5 cells; these cells
were processed and analyzed by flow cytometry. Infected cells
were detected by the expression of HSA or Thy markers; the
numbers of infected cells were converted to MOIs as previously
described (Rhodes et al., 2005). Results obtained from six sets
of experiments are summarized in Fig. 4A.
Virus produced from cell lines infected with two wild-type
viruses, one carrying the hsa marker and the other carrying the
thy marker, generated equivalent HSA and Thy titers. Viruses
produced from cell lines containing one wild-type vector
expressing HSA and one mutant vector expressing Thy all had
high Thy titers, although the Thy titers were slightly lower
(∼ twofold) than the HSA titers. Therefore, the mutant vector
RNAs, despite the fact that they did not carry functional gag
genes, were packaged and replicated efficiently.
Analyses of the expression of vector RNA in producer cells and
the selection of RNA packaged into virions
Compared with wild-type vectors, the twofold lower mutant
vector titers could have resulted from reduced cellular RNA
expression of the mutant vectors or from the preferential RNA
packaging of the wild-type vector. To distinguish these two
possibilities, we performed RNA analyses of the cellular and
virion RNAs. The gag genes in the wild-type and mutant
vectors are identical in sequence except at the mutated sites. The
sequence divergence in the mutated sites was used to
distinguish wild-type and mutant vector RNAs and determine
the ratios of these two RNAs by using an RT-PCR DNA
sequencing technique. Cytoplasmic RNA from the producer
cells and RNA from the virion generated by the producer cells
were isolated. These RNA samples were reverse transcribed
into DNA, and the resulting DNAwas analyzed by sequencing.
At the mutated sites, the wild-type and mutant vectors contained
different sequences, which generated two different signals; the
strength of each signal reflected the amount of the particular
vector in the sample. By comparing the wild-type and mutant
signals, we could determine the ratio of the two vector RNAs.
We compared the wild-type and mutant vector RNA ratios in
the six cell lines containing one wild-type and one mutant
vector. Data from at least five sets of experiments are
summarized in Figs. 4B and C. Analyses of the cellular RNA
demonstrated that, in all of the cell lines, wild-type vector and
gag mutants generated equivalent signals (Fig. 4B), indicating
that these vectors were expressed at similar levels. We then
analyzed the RNAs isolated from cell-free virions generated by
these cell lines. In the virion samples, gag mutant vector RNA
signals were approximately 1.7- to 3-fold lower than those of
wild-type vector RNAs (Fig. 4C). These results were consistent
with the observation that the mutant vector titers were
approximately twofold lower than the wild-type vector titers.
Fig. 4. Comparison of SIVagm vector titers and RNAs generated from cell lines
coexpressing two vectors. (A) SIVagm viral titers. In each cell line, the viral titer
of the TanH0G vector is set as 100%; TanH0G expresses a wild-type Gag/Gag–
Pol. Analyses of the wild-type and mutant viral RNAs in producer cells (B) and
cell-free virions (C). For panels B and C, in each sample, the amount of total
viral RNA is set as 100%. The results from at least three sets of independent
experiments are summarized; error bars, standard deviations. S239*,
TanT6GS239*; 1SSHS, TanT6G1SSHS; 2CCCC, TanT6G2CCCC.
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have close to two log decrease in RNA encapsidation (4.5% and
0.9% of the wild type, respectively; Fig. 2B). However, whencoexpressed with a wild-type vector, RNAs from these two
mutants could compete very well with the wild-type vector
RNA for encapsidation and were packaged about only about
twofold lower than the wild-type RNAs. These results indicated
that coexpression of a wild-type vector resulted in a 10- to 50-
fold rescue of the mutant viral RNA encapsidation, which
mainly comes from trans-packaging. Therefore, trans-packa-
ging is efficient and a major mechanism for SIVagm RNA
encapsidation.
Wild-type and mutant RNAs were copackaged efficiently during
virus assembly
To assess whether the RNAs encoding wild-type gag and
RNAs encoding mutant gag were well mixed and copackaged
into the virions, we examined the recombination frequencies
between two wild-type vectors, and between a wild-type vector
and a mutant vector. In the system we used to study cis- and
trans-packaging, each vector also carries a mutant, nonfunc-
tional gfp. The inactivating gfp mutation in the viruses
containing hsa is located at the 5′ end of the gfp gene, whereas
the mutation in the virus carrying thy is located at the 3′ end of
the gfp gene. The RNA from the wild-type vector and the RNA
from the mutant vector may or may not copackage together. If
the two RNAs from the same vectors are copackaged, the
resulting viruses are homozygous virions; if the RNAs from the
two different viruses are copackaged into the same virus
particle, then heterozygous virions are formed. Recombination
could occur during the reverse transcription of all viruses;
however, a functional gfp can only be reconstituted by
recombination events in the heterozygous viruses because the
two RNAs have different mutations in the gfp gene. If gfp
reconstitution occurs frequently between a wild-type gag virus
and a mutant gag virus, then their RNAs must be copackaged
efficiently. Therefore, recombination can be used to indicate
the efficiency of RNA copackaging and whether the viral RNAs
from different viruses are well mixed in the virus producer
cells.
We measured the frequencies of gfp reconstitution between
two wild-type gag viruses and between one wild-type gag virus
and a mutant gag virus. Results from at least three independent
experiments are shown in Fig. 5. We found that the frequencies
of gfp reconstitution were similar in all groups, indicating that
wild-type gag virus RNA and mutant gag virus RNA were
copackaged efficiently. This result also suggested that these two
types of RNAs were well mixed and did not traffic to different
parts of the cytoplasm.
Discussion
In this report, we sought to gain an understanding of the
SIVagm RNA packaging mechanism(s). We found that both
CCHC motifs in the NC domain of Gag are important in RNA
packaging because destroying either motif severely reduced
specific viral RNA encapsidation and viral infectivity. How-
ever, the second CCHC motif could be replaced by a CCHH
motif without significantly affecting RNA packaging or viral
Fig. 6. Comparison between SIVagm and HIV-1, HIV-2, SIVmac, and SIVmne.
(A) Phylogenetic relationship of the aforementioned five primate lentiviruses
inferred from the homology of the nucleic acid sequences of the full-length
genomes. One thousand bootstraps were performed and the results were
analyzed by using the Kimura 2-parameter method to calculate the distance
among the viruses and the neighbor-joining method to calculate branch lengths
of the phylogenetic tree (MEGA version 3.1 software). Cluster bootstrap values
above 95% are shown for each node; the bar indicates 0.05 Kimura-2 distance
units. (B) Amino acid sequence homology of Gag and NC of the five viruses.
Gag homology is indicated in shaded boxes whereas NC homology is indicated
in white boxes. Sequences of the strains described in various NC studies were
used to generate these comparisons. Accession numbers of the NCBI database:
HIV-1 (M19921), HIV-2 (X05291), SIVmac (M33262), SIVmne (AY817672),
and SIVagm (U58991).
Fig. 5. Recombination rates between two SIVagm vectors as indicators for the
efficiency of copackaging of wild-type and mutant vectors. Recombination rate
is calculated as (GFP MOI/ infection MOI)×100%. The results from at least
three sets of independent experiments are summarized; error bars, standard
errors. Abbreviations are the same as Fig. 4.
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abolished RNA packaging specificity and viral infectivity. We
also determined that SIVagm Gag proteins efficiently package
RNA in trans; furthermore, RNAs encoding functional or
nonfunctional Gag proteins were well mixed and copackaged
together efficiently.
To our knowledge, the roles of two zinc fingers in the NC
domain on RNA packaging have been studied in three other
primate lentiviruses: HIV-1, SIVmac, and SIVmne. Destroying
both zinc fingers led to decreased RNA packaging in HIV-2;
however, the role of each finger has not been studied (Kaye and
Lever, 1999). These viruses belong to three different branches
of the primate lentiviruses (Fig. 6A). Comparison of the viral
genomes illustrates that HIV-2, SIVmac, and SIVmne cluster
closer together in the same lineage (Fig. 6A); comparing the
strains used in the RNA packaging studies, these three viruses
have more than 83% amino acid sequence homology in Gag and
in NC (Fig. 6B). HIV-1 and SIVagm are more divergent than the
cluster of HIV-2, SIVmne, and SIVmac (Fig. 6A); SIVagm
shares 49% and 56% homology in Gag with HIV-1 and
SIVmne, respectively, and 40% and 42% homology in the NC
domain with HIV-1 and SIVmne, respectively (Fig. 6B). Our
study indicates that the requirements for NC zinc finger motifs
are different in SIVagm than in HIV-1, SIVmac, or SIVmne. In
HIV-1, both zinc fingers appear to be important for RNA
packaging, although the first finger is more important; one
mutant with the destroyed second finger could still package
25% of the viral genome compared with wild-type virus
(Gorelick et al., 1990). In SIVmne, either of the two fingers
appears to be sufficient for RNA packaging; destroying one
finger had little effect on RNA packaging but destroying both
reduced specific packaging sevenfold (Gorelick et al., 1999a;
Yovandich et al., 2001). In SIVmac, either finger has some role
in RNA packaging because destroying either finger decreased
specific packaging fivefold and destroying both fingers had a
14-fold effect (Akahata et al., 2003). In SIVagm, both fingersare required for RNA packaging; destroying either finger had a
similar 20–50-fold effect on RNA packaging (Fig. 2B).
Therefore, SIVagm differs from SIVmne or SIVmac because
both zinc fingers in SIVagm are required for RNA packaging.
SIVagm also differs from HIV-1 because destroying either of the
fingers has a similar level of reduction in RNA packaging.
Therefore, even within the primate lentiviruses, there are
significant differences in the roles of each zinc finger motif.
Because the NC domain plays a critical role in RNA selection
during virus assembly, the variations in the zinc finger motif
requirements most likely also reflect the differences in the
molecular interactions between Gag and viral RNA in these
viruses.
The full-length retroviral genome serves as template for Gag
translation and as genetic material for new virions. Different
viruses may use different mechanisms to balance these two
roles. For example, MLV separates the RNA into two pools,
whereas HIV-1 and HIV-2 do not appear to do so. This
difference may provide a basis for the different mechanisms
used for RNA packaging. For those viruses that do not have
distinct pools of RNA for each function, it is possible for RNA
encapsidation to occur in cis. There are putative theoretical
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packaging mechanism. For example, in the cis-packaging
mechanism, viral genomes encoding Gag proteins capable of
RNA recognition are preferentially encapsidated. Therefore, the
packaging mechanisms can serve as a process to select
functional genomes. Conversely, by using cis-packaging
mechanism, gag mutations could be selected against at two
different levels. These mutants cannot generate infectious
viruses, and their RNAs and information within the genome
cannot be easily rescued by other functional viruses. Trans-
packaging mechanism has the opposite properties; although
gag mutants are not selected against at two different levels, the
mechanism also does not select for RNA encoding functional
gag. However, trans-packaging mechanism allows the mixing
of genetic information via copackaging and recombination,
thereby possibly increasing the genetic variation of the viral
population, at least in the gag gene. Interestingly, of the primate
lentiviruses studied, HIV-1 and SIVagm appear to package
RNA efficiently in trans, whereas HIV-2 appears to package
RNA predominantly in cis. It is intriguing that these distantly
related viruses evolve to use different RNA packaging
mechanisms; furthermore, the employment of different mechan-
isms raised the questions about their effects on virus replication
and fitness. It is likely that future studies on the mechanisms of
viral replication will lead to a better understanding of the
selective advantages of the mechanisms they employ, which
may also shed light on the mechanisms of virus–host interaction
and viral pathogenesis.
Materials and methods
Construction of viral vectors based on SIVagm tan
Standard protocols were used to construct all of the plasmids
(Sambrook et al., 1989). Site-directed mutagenesis was
performed by overlapping PCR. The general structures of the
plasmids were confirmed by restriction enzyme mapping,
whereas regions generated by PCR were further characterized
by DNA sequencing to avoid inadvertent mutations.
Plasmid pTan contains a full-length, infectious molecular
clone of the tan1 strain of SIVagm (a generous gift from FanGao,
Duke University) (Soares et al., 1997). This molecular clone
carries functional gag–pol, env, vif, tat, rev, and nef, whereas
vpr contains an in-frame stop codon. A 19-bp linker was
inserted into the XhoI site to introduce an inactivating frameshift
mutation in env thus generating pTan1-XMS. A DNA fragment
containing the internal ribosomal entry site (IRES) sequences
from encephalomyocarditis virus fused to mouse heat-stable
antigen (hsa) was inserted into the BsiWI site in the nef of
pTan1-XMS to generate pTan1-IHSA. Vectors pSIVagmH0G
and pSIVagmT6G were derived from pTan1-XMS with markers
inserted into the nef gene; markers include hsa, green
fluorescence protein gene (gfp) (Chalfie et al., 1994), and
mouse thy1.2 gene (thy) (Giguere et al., 1985). Vector
pSIVagmH0G carries hsa-IRES-gfp, whereas pSIVagm-T6G
carries thy-IRES-gfp; in both vectors, gfp genes were inactivated
by mutations. To generate SIVagm vectors containing NCmutations, mutated DNA fragments (from site-directed muta-
genesis PCR) were digested with HpaI and BspEI and cloned
into pTan1-IHSA digested with HpaI and BspEI. Vector
pTanT6GS237* was generated by inserting a linker with an
in-frame stop codon into the SanDI site, thereby creating a stop
codon at codon 237 of gag. Vectors pTanT6G2CCCC and
pTanT6G1SSHS were generated by replacing the BspEI to
Tth111I fragment of pSIVagmT6G with that of the mutants
containing CCHC/CCCC and SSHS/CCHC mutations, res-
pectively. For clarity, pSIVagmH0G and pSIVagmT6G are
referred to as pTanH0G and pTanT6G in the following text,
respectively.
Cell culture, transfection, infection, flow cytometry analyses,
and measurement of viral titers
Hut/CCR5 is a human T cell line modified to express CCR5,
and 293T is a human kidney fibroblast cell line. Cell lines were
grown at 37 °C with 5% CO2, in Dulbecco's modified Eagle's
medium (293T) or Roswell Park Memorial Institute-1640
medium RPMI (Hut/CCR5) supplemented with 10% fetal calf
serum and antibiotics.
DNA transfection was performed using the calcium
phosphate method (Sambrook et al., 1989). To generate
pseudotyped viruses, pTan vector was transfected with pIIINL
(AD8)env, which expresses CCR5-tropic HIV-1 Env (Freed et
al., 1995), or pHCMV-G, which expresses vesicular stomatitis
virus G protein (VSV G) (Burns et al., 1993). Supernatants were
harvested 36 to 48 h later from the producer cells, clarified
through a 0.22-μm or 0.45-μm filter, and either used directly for
infection or stored at −80 °C and thawed prior to infection.
Virus infections were performed in the presence of polybrene,
infected cells were stained with phycoerythrin-conjugated anti-
HSA antibody (BD PharMingen) or allophycocyanin-conju-
gated anti-Thy1.2 antibody (eBiosciences). Flow cytometry
analyses were performed using a FACSCalibur (BD Bios-
ciences) and data acquired were analyzed using Flowjo software
(Tree Star). Cell sorting was performed using a FACSVantage
SE system with the FACSDiVa digital option (BD Biosciences).
To generate cell lines containing two SIVagm vectors,
sequential infections were performed using low multiplicity of
infection (MOI). HIV-1 helper construct was used to mobilize
mutant SIVagm vectors. MOI was calculated from the number
of infected cells in the total live cells based on Poisson
distribution (Rhodes et al., 2005).
Measurement of virion production and analyses of cellular and
virion RNA
Virus production was monitored by the amount of CA (p27)
measured by the SIV p27 ELISA kit (Retro Teck) or by reverse
transcriptase (RT) activity measured by the standard protocol
(Cheslock et al., 2000; Temin andMizutani, 1970). Cytoplasmic
RNA was isolated using a standard protocol (Sambrook et al.,
1989). Virion RNA was isolated either as previously described
(Fu et al., 1994) or using Trizol reagent as recommended by the
manufacturer (Invitrogen).
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mutants were determined by quantitative real-time PCR of
viruses produced from cells infected with an SIVagm vector.
These cells were produced by infecting 293T cells with viruses
derived from VSV G-pseudotyped SIVagm vector. Cell-free
viruses produced from the infected 293T cells were collected
48 h postinfection and viral RNA was isolated from virions by
standard protocol (Fu et al., 1994). The amounts of SIVagm
RNA were determined by quantitative real-time RT-PCR using
primers and probe annealed to sequences in MA-primers (5′-
GCGGGACACTCGGCACT-3′ and 5′-CGTTCGGGCGT-
AAGCGTC-3′) and probe (5′-TAMTCAGGGAGGAATTTGG-
ACACATTTGAGAAATAMRA-3′). Plasmid DNA (pTan1-XMS)
was used to generate standard curves for real-time RT-PCR
detection.
The percentage of wild-type or mutant viral RNA expressed
in cells or packaged in the virions was determined using an RT-
PCR sequencing method as previously described (Nikolaitchik
et al., 2006). Briefly, RT-PCR was performed using viral RNA
as template, and the resulting DNA was analyzed by a
sequencing reaction. The ratios between the wild-type and
mutant RNAs were calculated based on the heights of the peaks
of the sequencing reactions. Standard curves were generated by
mixing varied ratios of wild-type and mutant plasmids and
subjecting the mixtures to PCR and sequencing reactions.
Acknowledgments
We thank Anne Arthur for expert editorial help, Vinay K.
Pathak for scientific input and discussions of this project, and
Vinay K. Pathak and Robert Gorelick for critical reading and
suggestions of the manuscript.
This research was supported by the Intramural Research
Program of the NIH, National Cancer Institute, Center for
Cancer Research.
References
Adam, M.A., Miller, A.D., 1988. Identification of a signal in a murine retrovirus
that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 62
(10), 3802–3806.
Akahata, W., Ido, E., Hayami, M., 2003. Mutational analysis of two zinc-finger
motifs in the nucleocapsid protein of simian immunodeficiency virus
mac239. J. Gen. Virol. 84 (Pt. 6), 1641–1648.
Aldovini, A., Young, R.A., 1990. Mutations of RNA and protein sequences
involved in human immunodeficiency virus type 1 packaging result in
production of noninfectious virus. J. Virol. 64 (5), 1920–1926.
Bender, M.A., Palmer, T.D., Gelinas, R.E., Miller, A.D., 1987. Evidence that the
packaging signal of Moloney murine leukemia virus extends into the gag
region. J. Virol. 61 (5), 1639–1646.
Berkowitz, R.D., Hammarskjold, M.L., Helga-Maria, C., Rekosh, D., Goff, S.P.,
1995a. 5′ regions of HIV-1 RNAs are not sufficient for encapsidation:
implications for the HIV-1 packaging signal. Virology 212 (2), 718–723.
Berkowitz, R.D., Ohagen, A., Hoglund, S., Goff, S.P., 1995b. Retroviral
nucleocapsid domains mediate the specific recognition of genomic viral
RNAs by chimeric Gag polyproteins during RNA packaging in vivo.
J. Virol. 69 (10), 6445–6456.
Berkowitz, R., Fisher, J., Goff, S.P., 1996. RNA packaging. Curr. Top.
Microbiol. Immunol. 214, 177–218.
Bess Jr., J.W., Powell, P.J., Issaq, H.J., Schumack, L.J., Grimes, M.K.,Henderson, L.E., Arthur, L.O., 1992. Tightly bound zinc in human
immunodeficiency virus type 1, human T-cell leukemia virus type I, and
other retroviruses. J. Virol. 66 (2), 840–847.
Broussard, S.R., Staprans, S.I., White, R., Whitehead, E.M., Feinberg, M.B.,
Allan, J.S., 2001. Simian immunodeficiency virus replicates to high levels in
naturally infected African green monkeys without inducing immunologic or
neurologic disease. J. Virol. 75 (5), 2262–2275.
Burns, J.C., Friedmann, T., Driever, W., Burrascano, M., Yee, J.K., 1993.
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors:
concentration to very high titer and efficient gene transfer into mammalian
and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90 (17), 8033–8037.
Butsch, M., Boris-Lawrie, K., 2000. Translation is not required To generate
virion precursor RNA in human immunodeficiency virus type 1-infected T
cells. J. Virol. 74 (24), 11531–11537.
Butsch, M., Boris-Lawrie, K., 2002. Destiny of unspliced retroviral RNA:
ribosome and/or virion? J. Virol. 76 (7), 3089–3094.
Certo, J.L., Kabdulov, T.O., Paulson, M.L., Anderson, J.A., Hu,W.S., 1999. The
nucleocapsid domain is responsible for the ability of spleen necrosis virus
(SNV) Gag polyprotein to package both SNV and murine leukemia virus
RNA. J. Virol. 73 (11), 9170–9177.
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W., Prasher, D.C., 1994. Green
fluorescent protein as a marker for gene expression. Science 263, 802–805.
Chen, Z., Telfer, P., Gettie, A., Reed, P., Zhang, L., Ho, D.D., Marx, P.A., 1996.
Genetic characterization of a new West African simian immunodeficiency
virus SIVsm: geographic clustering of household-derived SIV strains with
human immunodeficiency virus type 2 subtypes and genetically diverse
viruses from a single feral sooty mangabey troop. J. Virol. 70, 3617–3627.
Cheslock, S.R., Anderson, J.A., Hwang, C.K., Pathak, V.K., Hu, W.S., 2000.
Utilization of nonviral sequences for minus-strand DNA transfer and gene
reconstitution during retroviral replication. J. Virol. 74 (20), 9571–9579.
Dorman, N., Lever, A., 2000. Comparison of viral genomic RNA sorting
mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and
Moloney murine leukemia virus. J. Virol. 74 (23), 11413–11417.
Dupraz, P., Oertle, S., Meric, C., Damay, P., Spahr, P.F., 1990. Point mutations in
the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein.
J. Virol. 64 (10), 4978–4987.
Embretson, J.E., Temin, H.M., 1987. Lack of competition results in efficient
packaging of heterologous murine retroviral RNAs and reticuloendotheliosis
virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper
cell line. J. Virol. 61 (9), 2675–2683.
Freed, E.O., Englund, G., Martin, M.A., 1995. Role of the basic domain of
human immunodeficiency virus type 1 matrix in macrophage infection.
J. Virol. 69 (6), 3949–3954.
Fu, W., Gorelick, R.J., Rein, A., 1994. Characterization of human immunode-
ficiency virus type 1 dimmer RNA from wild-type and protease-defective
virions. J. Virol. 68 (8), 5013–5018.
Gao, F., Bailes, E., Robertson, D.L., Chen, Y., Rodenburg, C.M., Michael, S.F.,
Cummins, L.B., Arthur, L.O., Peeters, M., Shaw, G.M., Sharp, P.M., Hahn,
B.H., 1999. Origin of HIV-1 in the chimpanzee Pan troglodytes. Nature 397
(6718), 436.
Giguere, V., Isobe, K.-I., Grosveld, F., 1985. Structure of the murine Thy-1 gene.
EMBO J. 4, 2017–2024.
Gorelick, R.J., Henderson, L.E., Hanser, J.P., Rein, A., 1988. Point mutants of
Moloney murine leukemia virus that fail to package viral RNA: evidence for
specific RNA recognition by a “zinc finger-like” protein sequence. Proc.
Natl. Acad. Sci. U.S.A. 85 (22), 8420–8424.
Gorelick, R.J., Nigida Jr., S.M., Bess Jr., J.W., Arthur, L.O., Henderson, L.E.,
Rein, A., 1990. Noninfectious human immunodeficiency virus type 1
mutants deficient in genomic RNA. J. Virol. 64 (7), 3207–3211.
Gorelick, R.J., Chabot, D.J., Rein, A., Henderson, L.E., Arthur, L.O., 1993. The
two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid
protein are not functionally equivalent. J. Virol. 67 (7), 4027–4036.
Gorelick, R.J., Chabot, D.J., Ott, D.E., Gagliardi, T.D., Rein, A., Henderson,
L.E., Arthur, L.O., 1996. Genetic analysis of the zinc finger in the
Moloney murine leukemia virus nucleocapsid domain: replacement of
zinc-coordinating residues with other zinc-coordinating residues yields
noninfectious particles containing genomic RNA. J. Virol. 70 (4),
2593–2597.
219W. Fu et al. / Virology 363 (2007) 210–219Gorelick, R.J., Benveniste, R.E., Gagliardi, T.D., Wiltrout, T.A., Busch, L.K.,
Bosche, W.J., Coren, L.V., Lifson, J.D., Bradley, P.J., Henderson, L.E.,
Arthur, L.O., 1999a. Nucleocapsid protein zinc-finger mutants of simian
immunodeficiency virus strain mne produce virions that are replication
defective in vitro and in vivo. Virology 253 (2), 259–270.
Gorelick, R.J., Gagliardi, T.D., Bosche, W.J., Wiltrout, T.A., Coren, L.V.,
Chabot, D.J., Lifson, J.D., Henderson, L.E., Arthur, L.O., 1999b. Strict
conservation of the retroviral nucleocapsid protein zinc finger is strongly
influenced by its role in viral infection processes: characterization of HIV-1
particles containing mutant nucleocapsid zinc-coordinating sequences.
Virology 256 (1), 92–104.
Green, L.M., Berg, J.M., 1989. A retroviral Cys–Xaa2–Cys–Xaa4–His–Xaa4–
Cys peptide binds metal ions: spectroscopic studies and a proposed three-
dimensional structure. Proc. Natl. Acad. Sci. U.S.A. 86 (11), 4047–4051.
Hahn, B.H., Shaw, G.M., De, K.M., Cock, Sharp, P.M., 2000. AIDS as a
zoonosis: scientific and public health implications. Science 287 (5453),
607–614.
Hirsch, V.M., 2004. What can natural infection of African monkeys with simian
immunodeficiency virus tell us about the pathogenesis of AIDS? AIDS Rev.
6 (1), 40–53.
Hirsch, V.M., Olmsted, R.A., Murphey-Corb, M., Purcell, R.H., Johnson, P.R.,
1989. An African primate lentivirus (SIVsm) closely related to HIV-2.
Nature 339, 389–392.
Huet, T., Cheynier, R., Meyerhans, A., Roelants, G., Wain-Hobson, S., 1990.
Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature
345, 356.
Katoh, I., Kyushiki, H., Sakamoto, Y., Ikawa, Y., Yoshinaka, Y., 1991. Bovine
leukemia virus matrix-associated protein MA(p15): further processing and
formation of a specific complex with the dimer of the 5′-terminal genomic
RNA fragment. J. Virol. 65 (12), 6845–6855.
Kaye, J.F., Lever, A.M., 1998. Nonreciprocal packaging of human immuno-
deficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of
Gag in RNA encapsidation. J. Virol. 72 (7), 5877–5885.
Kaye, J.F., Lever, A.M., 1999. Human immunodeficiency virus types 1 and 2
differ in the predominant mechanism used for selection of genomic RNA for
encapsidation. J. Virol. 73 (4), 3023–3031.
Kaye, J.F., Richardson, J.H., Lever, A.M., 1995. cis-Acting sequences involved
in human immunodeficiency virus type 1 RNA packaging. J. Virol. 69 (10),
6588–6592.
Leis, J., Baltimore, D., Bishop, J.M., Coffin, J., Fleissner, E., Goff, S.P.,
Oroszlan, S., Robinson, H., Skalka, A.M., Temin, H.M., et al., 1988.
Standardized and simplified nomenclature for proteins common to all
retroviruses. J. Virol. 62 (5), 1808–1809.
Lever, A.M., 2000. HIV RNA packaging and lentivirus-based vectors. Adv.
Pharmacol. 48, 1–28.
Lever, A., Gottlinger, H., Haseltine, W., Sodroski, J., 1989. Identification of a
sequence required for efficient packaging of human immunodeficiency virus
type 1 RNA into virions. J. Virol. 63 (9), 4085–4087.
Levin, J.G., Rosenak, M.J., 1976. Synthesis of murine leukemia virus proteins
associated with virions assembled in actinomycin D-treated cells: evidence
for persistence of viral messenger RNA. Proc. Natl. Acad. Sci. U.S.A. 73
(4), 1154–1158.
Levin, J.G., Grimley, P.M., Ramseur, J.M., Berezesky, I.K., 1974. Deficiency of
60 to 70S RNA in murine leukemia virus particles assembled in cells treated
with actinomycin D. J. Virol. 14 (1), 152–161.
Luban, J., Goff, S.P., 1991. Binding of human immunodeficiency virus type 1
(HIV-1) RNA to recombinant HIV-1 gag polyprotein. J. Virol. 65 (6),
3203–3212.
McBride, M.S., Panganiban, A.T., 1996. The human immunodeficiency virustype 1 encapsidation site is a multipartite RNA element composed of
functional hairpin structures. J. Virol. 70 (5), 2963–2973.
Mougel, M., Barklis, E., 1997. A role for two hairpin structures as a core RNA
encapsidation signal in murine leukemia virus virions. J. Virol. 71 (10),
8061–8065.
Muller, M.C.B.-S.F., 2003. SIVagm: genetic and biological features associated
with replication. Front. Biosci. 8, 1170–1185.
Nikolaitchik, O., Rhodes, T.D., Ott, D., Hu, W.S., 2006. Effects of mutations in
the human immunodeficiency virus type 1 Gag gene on RNA packaging and
recombination. J. Virol. 80 (10), 4691–4697.
Novembre, F.J., Hirsch, V.M., McClure, H.M., Fultz, P.N., Johnson, P.R., 1992.
SIV from stump-tailed macaques: molecular characterization of a highly
transmissible primate lentivirus. Virology 186, 783–787.
Ott, D.E., Coren, L.V., Gagliardi, T.D., 2005. Redundant roles for nucleocapsid
and matrix RNA-binding sequences in human immunodeficiency virus type
1 assembly. J. Virol. 79 (22), 13839–13847.
Poon, D.T., Li, G., Aldovini, A., 1998. Nucleocapsid and matrix protein
contributions to selective human immunodeficiency virus type 1 genomic
RNA packaging. J. Virol. 72 (3), 1983–1993.
Rein, A., Harvin, D.P., Mirro, J., Ernst, S.M., Gorelick, R.J., 1994. Evidence that
a central domain of nucleocapsid protein is required for RNA packaging in
murine leukemia virus. J. Virol. 68 (9), 6124–6129.
Rhodes, T.D., Nikolaitchik, O., Chen, J., Powell, D., Hu, W.S., 2005. Genetic
recombination of human immunodeficiency virus type 1 in one round of
viral replication: effects of genetic distance, target cells, accessory genes,
and lack of high negative interference in crossover events. J. Virol. 79 (3),
1666–1677.
Rossio, J.L., Esser, M.T., Suryanarayana, K., Schneider, D.K., Bess Jr., J.W.,
Vasquez, G.M., Wiltrout, T.A., Chertova, E., Grimes, M.K., Sattentau, Q.,
Arthur, L.O., Henderson, L.E., Lifson, J.D., 1998. Inactivation of human
immunodeficiency virus type 1 infectivity with preservation of conforma-
tional and functional integrity of virion surface proteins. J. Virol. 72 (10),
7992–8001.
Salemi, M., De Oliveira, T., Courgnaud, V., Moulton, V., Holland, B., Cassol, S.,
Switzer, W.M., Vandamme, A.-M., 2003. Mosaic genomes of the six major
primate lentivirus lineages revealed by phylogenetic analyses. J. Virol. 77
(13), 7202–7213.
Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning: A
Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY.
Soares, M.A., Robertson, D.L., Hui, H., Allan, J.S., Shaw, G.M., Hahn, B.H.,
1997. A full-length and replication-competent proviral clone of SIVAGM
from tantalus monkeys. Virology 228 (2), 394–399.
Summers, M.F., Henderson, L.E., Chance, M.R., Bess Jr., J.W., South, T.L.,
Blake, P.R., Sagi, I., Perez-Alvarado, G., Sowder III, R.C., Hare, D.R., et al.,
1992. Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of
intact viruses and the solution-state structure of the nucleocapsid protein
from HIV-1. Protein Sci. 1 (5), 563–574.
Temin, H.M., Mizutani, S., 1970. RNA-dependent DNA polymerase in virions
of Rous sarcoma virus. Nature 226 (252), 1211–1213.
Vogt, V.M., 1997. Retroviral Virions and Genomes. Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY.
Yovandich, J.L., Chertova, E.N., Kane, B.P., Gagliardi, T.D., Bess Jr., J.W.,
Sowder II, R.C., Henderson, L.E., Gorelick, R.J., 2001. Alteration of zinc-
binding residues of simian immunodeficiency virus p8(NC) results in subtle
differences in gag processing and virion maturation associated with
degradative loss of mutant NC. J. Virol. 75 (1), 115–124.
Zhang, Y., Barklis, E., 1995. Nucleocapsid protein effects on the specificity of
retrovirus RNA encapsidation. J. Virol. 69 (9), 5716–5722.
